Related Experiment Videos
[Pharmacodynamics of anticancer agents]
1Division of Hematology-Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 1, 1993
Summary
This review highlights how understanding anticancer pharmacodynamics, the link between drug effects and measurements, is crucial for effective cancer therapy. Incorporating this knowledge enables personalized treatment strategies for better patient outcomes.
Area of Science:
- Pharmacology
- Oncology
- Clinical Trials
Context:
- Anticancer pharmacodynamics, the relationship between drug concentration and effect, is vital for optimizing cancer treatment.
- Current limitations in applying pharmacokinetic data to cancer therapy stem from a lack of pharmacodynamic information.
- Studies reviewed encompass pharmacodynamics of toxicities, tumor response, and cellular effects.
Purpose:
- To review existing studies on anticancer pharmacodynamics.
- To emphasize the need for pharmacodynamic data to enhance pharmacokinetic applications in cancer therapy.
- To advocate for the development of pharmacodynamic models for improved drug administration.
Summary:
- Pharmacodynamics links drug measurements to therapeutic or toxic responses.
- Integrating pharmacodynamic knowledge facilitates individualized therapy, adaptive control strategies (ACF), and targeted systemic exposure strategies (TSES).
- A prospective trial in Acute Lymphocytic Leukemia is evaluating individualized therapy using TSES with ACF.
Impact:
- Advances in understanding anticancer pharmacodynamics can lead to more personalized and effective cancer chemotherapy.
- The development of pharmacodynamic models can optimize the administration of anticancer drugs.
- This research supports the establishment of oncological pharmacology-based optimal drug administration.